HALDOL DECANOATE: ASPECTS OF DRUG USE IN INDIVIDUALS IN NORTHEASTERN BRAZIL
DOI:
https://doi.org/10.16891/2317-434X.v11.e3.a2023.pp3054-3060Abstract
Objective: to identify socio-demographic aspects, diagnosis and administration of Haldol Decanoate in patients of Psychosocial Care Center in northeastern Brazil. Methods: The study is documentary, with quantitative design, with collection in medical records of users of Psychosocial Care Center, in the city of Crato, Ceará, northeastern Brazil. Data collection occurred from June to August 2022. Results: 75 medical records were identified, of which 51 met the criteria of this study and constitute the research sample. The data extracted are related to age, gender, marital status, base diagnosis and dosage range that received the injectable Haldol Decanoate. Conclusion: The medical records evaluated presented higher prevalence of age 31 - 40 years old, male gender, single marital status, schizophrenia base diagnosis and dosing interval of Haldol Decanoate of 15 days using 1 ampoule.